Surgical staging of non-small cell lung carcinoma: when should we routinely resect supraclavicula

Main Article Content

Ignacio Sastre
Manuel I. España
Roberto Ceballos
Mario E. F. Bustos


Background: Accurate staging after the diagnosis of lung carcinoma is essential to select an appropriate therapy.
Objective: The aim of the present study is to describe the characteristics of patients with non-small cell lung carcinoma in whom supraclavicular lymph node resection would detect non-palpable (N3 supraclavicular disease) lymph node metastases.
Material and methods: Data from patients undergoing mediastinal surgical staging for non-small cell lung cancer using cervical mediastinoscopy and resection of supraclavicular lymph nodes were collected between December 2016 and December 2019.
Results: A total of 60 patients were included; 76.6% were men. Mean tumor size was 4.7 cm ad mean lymph node stations evaluated by mediastinoscopy was 2.37 ± 1.44 (SD). All the patients underwent supraclavicular lymph node resection and the result was positive for epithelial carcinoma in 21 cases (35%). Of the 21 cases with N3 supraclavicular disease, 2 patients were recorded as skip metastases and the remaining cases were association with mediastinal N2 disease (p = 0.0424). There was a significant association between central tumor and N3 supraclavicular disease (p = 0.0148).
Conclusion: Supraclavicular lymph node resection may be recommended in patients with suspected or confirmed N2 lymph node disease and central tumors, before considering a multimodal therapeutic approach including surgery


Download data is not yet available.

Article Details

How to Cite
Sastre, I., España, M. I., Ceballos, R., & Bustos, M. E. F. (2023). Surgical staging of non-small cell lung carcinoma: when should we routinely resect supraclavicula. Revista Argentina De Cirugía, 115(3), 223–232. Retrieved from
Original Article

Similar Articles

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)